Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
March 14, 2018
Auris Medical Provides Business Update
Zug, Switzerland, March 13, 2018 - Auris Medical Holding AG (EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in ...
March 14, 2018
Rockwell Medical, Inc. Appoints Two Independent and Experienced Life Sciences Executives to Board of Directors
WIXOM, Mich., March 13, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (RMTI), (the “Company”) announced today that it has unanimously appointed Lisa Colleran and Benjamin ...
March 14, 2018
Kiadis Pharma to Present at the Cowen and Company 38th Annual Health Care Conference
Amsterdam, The Netherlands, March 14, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS), a clinical stage biopharmaceutical company developing ...
March 14, 2018
BioDelivery Sciences to Present at the Oppenheimer 28th Annual Healthcare Conference
RALEIGH, N.C., March 14, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (BDSI), a specialty pharmaceutical company with a focus in pain management and addiction ...
March 14, 2018
MannKind Corporation to Present at Oppenheimer 28th Annual Healthcare Conference
WESTLAKE VILLAGE, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- MannKind Corporation (MNKD) focused on the development and commercialization of inhaled therapeutic products for patients with ...
March 14, 2018
FDA Acceptance of IND for Tyme to Begin Phase II Trial in Pancreatic Cancer
NEW YORK, March 14, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (TYME) (“Tyme” or the “Company”) announced today that the U.S. Food and Drug Administration (“FDA”) ...
March 14, 2018
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financial Results
SAN DIEGO, March 14, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA), today provided a corporate update and reported financial results for the fourth quarter and full-year ...
March 14, 2018
Lipocine to Present at the Oppenheimer 28th Annual Healthcare Conference
SALT LAKE CITY, March 14, 2018 /PRNewswire/ -- Lipocine Inc. (LPCN), a specialty pharmaceutical company, announced today that Dr. Mahesh Patel, Chairman, President and CEO, will ...
March 14, 2018
Spring Bank Announces Presentation of Combined Inarigivir 25 mg and 50 mg 12 and 24 Week ACHIEVE Results Demonstrating Enhanced Anti-Viral Efficacy in HBeAg-Negative Patients
HOPKINTON, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (SBPH) today announced that Nezam Afdhal, M.D., D.Sc., chief medical officer of Spring ...
March 14, 2018
Achaogen to Present at Needham & Company’s 17th Annual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., March 14, 2018 (GLOBE NEWSWIRE) -- Achaogen, Inc. (AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative ...
March 8, 2018
Mirati Therapeutics Reports Fourth Quarter And Full-Year 2017 Financial Results
SAN DIEGO, March 8, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (MRTX), a clinical stage oncology biotechnology company, today reported financial results for the fourth quarter and ...
March 8, 2018
CytoSorbents Achieves Record Revenue and Product Sales Growth in 2017
MONMOUTH JUNCTION, N.J., March 8, 2018 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using CytoSorb® blood purification to treat deadly inflammation in critically-ill ...
March 8, 2018
TherapeuticsMD Announces FDA Acceptance of New Drug Application (NDA) and Prescription Drug User Fee Act (PDUFA) Date for TX-001HR
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced the acceptance of the NDA for TX-001HR by the U.S. Food and ...
March 8, 2018
Pernix Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
MORRISTOWN, N.J., March 08, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (PTX), a specialty pharmaceutical company, announced today financial results for the three and ...
March 8, 2018
BioLife Solutions Announces Fourth Quarter and Full Year 2017 Financial Results
BOTHELL, Wash., March 8, 2018 /PRNewswire/ -- BioLife Solutions, Inc. (BLFS) ("BioLife"), the leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue ...
March 8, 2018
MediWound to Present at Two Investor Conferences
YAVNE, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (MDWD), a fully-integrated biopharmaceutical company bringing innovative therapies to address unmet needs in severe burn ...
March 8, 2018
VBL Therapeutics Announces Top-Line Results from Pivotal Phase 3 GLOBE Study in Patients with Recurrent Glioblastoma
TEL AVIV, Israel, March 08, 2018 (GLOBE NEWSWIRE) -- VBL Therapeutics (VBLT), today reported top-line results from its pivotal Phase 3 GLOBE study in patients ...
March 8, 2018
BrainStorm Announces Operational Highlights and Financial Results for the Year Ended December 31, 2017
NEW YORK and PETACH TIKVAH, Israel, March 8, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell technologies for neurodegenerative ...
March 8, 2018
Aptose To Release Fourth Quarter and Year End December 31, 2017 Financial Results and Hold Conference Call on March 27, 2018
SAN DIEGO and TORONTO, March 08, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (APTO) (APS.TO), a clinical-stage biotechnology company developing first-in-class agents that target the ...
March 8, 2018
Innate Pharma Hosts R&D Day Today in London
Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class therapeutic antibodies for cancer, will today outline development ...
Page 80 of 138